Repligen Corp. (RGEN)
117.78
-0.54
(-0.46%)
USD |
NASDAQ |
Apr 02, 16:00
117.09
-0.69
(-0.59%)
After-Hours: 07:38
Repligen Market Cap : 6.610B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Masimo Corp. | 9.354B |
| Orthofix Medical, Inc. | 459.68M |
| InfuSystem Holdings, Inc. | 187.80M |
| Tandem Diabetes Care, Inc. | 1.259B |
| Plus Therapeutics, Inc. | 24.43M |
Market Cap Related Metrics
| PE Ratio | 136.24 |
| PS Ratio | 9.024 |
| Price to Book Value | 3.150 |
| Price to Free Cash Flow | 72.66 |
| Price | 117.78 |
| Earnings Yield | 0.73% |
| Operating PE Ratio | 130.88 |
| Normalized PE Ratio | 144.34 |